Table #: Results of chromosome analysis in .... [erythrocytes / lymphocytes / spermatogonia / other)] (State mean ± standard deviation and individual numbers for critical findings)
|
| Control | Low dose | Mid dose | High dose | |||||||
| Sampling time (h) |
| 12 | 18 | 24 | 12 | 18 | 24 | 12 | 18 | 24 | |
| Number of cells evaluated |
|
|
|
|
|
|
|
|
|
| |
| Toxicity, specify effects |
|
|
|
|
|
|
|
|
|
| |
| Chromatid aberrations | Gaps |
|
|
|
|
|
|
|
|
|
|
| Breaks |
|
|
|
|
|
|
|
|
|
| |
| Interchanges |
|
|
|
|
|
|
|
|
|
| |
| Isochromatid aberrations | Gaps |
|
|
|
|
|
|
|
|
|
|
| Breaks |
|
|
|
|
|
|
|
|
|
| |
| Interchanges |
|
|
|
|
|
|
|
|
|
| |
| Mitotic index |
|
|
|
|
|
|
|
|
|
| |
| Polyploidy |
|
|
|
|
|
|
|
|
|
| |
| Endo reduplication |
|
|
|
|
|
|
|
|
|
| |